Biodesix regains Nasdaq minimum bid price compliance; matter closed

BIODESIX INC

Received Nasdaq letter on Sept. 26, 2025 confirming compliance regained.
Common stock closed at $1.00+ for 10 consecutive business days.
Previously disclosed bid price deficiency on March 24, 2025.
No further action required; ongoing listing on Nasdaq Global Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.